[{"genesymbol":"CYP2C19","diplotype":"*17/*17","function1":"Increased function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two increased function alleles","diplotypekey":{"CYP2C19": {"*17": 2}},"generesult":"Ultrarapid Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of an increased function allele. Based on the genotype result this patient is predicted to be an ultrarapid metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Ultrarapid Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*17","function1":"Increased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one increased function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*17": 1}},"generesult":"Rapid Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of an increased function allele. Based on the genotype result this patient is predicted to be a rapid metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Rapid Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*17","function1":"Increased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one increased function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*17": 1}},"generesult":"Rapid Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of an increased function allele. Based on the genotype result this patient is predicted to be a rapid metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Rapid Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*17","function1":"Increased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one increased function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*17": 1}},"generesult":"Rapid Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of an increased function allele. Based on the genotype result this patient is predicted to be a rapid metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Rapid Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*17","function1":"Increased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one increased function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*17": 1}},"generesult":"Rapid Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of an increased function allele. Based on the genotype result this patient is predicted to be a rapid metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Rapid Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*18","function1":"Increased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one increased function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*18": 1}},"generesult":"Rapid Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of an increased function allele. Based on the genotype result this patient is predicted to be a rapid metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Rapid Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*28","function1":"Increased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one increased function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*28": 1}},"generesult":"Rapid Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of an increased function allele. Based on the genotype result this patient is predicted to be a rapid metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Rapid Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*38","function1":"Increased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one increased function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*38": 1}},"generesult":"Rapid Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of an increased function allele. Based on the genotype result this patient is predicted to be a rapid metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Rapid Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*1","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*1": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*11","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*11": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*13","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*13": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*15","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*15": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*18","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*18": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*28","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*28": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*38/*38","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*38": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*11","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*1": 1, "*11": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*13","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*1": 1, "*13": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*15","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*1": 1, "*15": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*18","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*1": 1, "*18": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*28","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*1": 1, "*28": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*38","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*1": 1, "*38": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*13","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*11": 1, "*13": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*15","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*11": 1, "*15": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*18","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*11": 1, "*18": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*28","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*11": 1, "*28": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*38","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*11": 1, "*38": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*15","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*13": 1, "*15": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*18","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*13": 1, "*18": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*28","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*13": 1, "*28": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*38","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*13": 1, "*38": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*18","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*15": 1, "*18": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*28","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*15": 1, "*28": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*38","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*15": 1, "*38": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*28","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*18": 1, "*28": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*38","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*18": 1, "*38": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*38","function1":"Normal function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two normal function alleles","diplotypekey":{"CYP2C19": {"*28": 1, "*38": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of a normal function allele. Based on the genotype result this patient is predicted to be an normal metabolizer of CYP2C19 substrates. There is no reason to selectively adjust the dose of most medications that are metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Normal Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*10","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*10": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*16","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*16": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*19","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*19": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*25","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*26","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*9","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*9": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*11","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*11": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*13","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*13": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*15","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*15": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*18","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*18": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*28","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*28": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*38","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*38": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*16","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*16": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*19","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*19": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*25","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*26","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*16","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*16": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*19","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*19": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*25","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*26","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*16","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*16": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*19","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*19": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*25","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*26","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*18","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*18": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*28","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*28": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*38","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*38": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*19","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*19": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*25","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*26","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*28","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*28": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*38","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*38": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*28","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*28": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*38","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*38": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*28","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*28": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*38","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*38": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*11","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*11": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*13","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*13": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*15","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*15": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*18","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*18": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*28","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*28": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*38","function1":"Decreased function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*38": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*17","function1":"Decreased function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*17": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*17","function1":"Decreased function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*17": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*19","function1":"Decreased function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*19": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*25","function1":"Decreased function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*26","function1":"Decreased function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*17","function1":"Decreased function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one decreased function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*17": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*10","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*10": 2}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*16","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*16": 2}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*19","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*19": 2}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*25","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*25": 2}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*26","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*26": 2}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*9","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*9": 2}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*16","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*10": 1, "*16": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*19","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*10": 1, "*19": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*25","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*10": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*26","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*10": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*19","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*16": 1, "*19": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*25","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*16": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*26","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*16": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*25","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*19": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*26","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*19": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*26","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*25": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*10","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*9": 1, "*10": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*16","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*9": 1, "*16": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*19","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*9": 1, "*19": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*25","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*9": 1, "*25": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*26","function1":"Decreased function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two decreased function alleles","diplotypekey":{"CYP2C19": {"*9": 1, "*26": 1}},"generesult":"Likely Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele OR one copy of an increased function allele and one copy of a decreased function allele OR two copies of a decreased function allele. Based on the genotype result this patient MAY be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*2","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*2": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*22","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*22": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*24","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*24": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*3","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*3": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*35","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*35": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*36","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*36": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*37","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*37": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*4","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*4": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*5","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*5": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*6","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*6": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*7","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*7": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*8","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*8": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*22","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*22": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*24","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*24": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*35","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*35": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*36","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*36": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*37","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*37": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*22","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*22": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*24","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*24": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*35","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*35": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*36","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*36": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*37","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*37": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*22","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*22": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*24","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*24": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*35","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*35": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*36","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*36": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*37","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*37": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*22","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*22": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*24","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*24": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*35","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*35": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*36","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*36": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*37","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*37": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*11","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*11": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*13","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*13": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*15","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*15": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*18","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*18": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*28","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*28": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*28","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*28": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*28","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*28": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*35","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*35": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*36","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*36": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*37","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*37": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*11","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*11": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*13","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*13": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*15","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*15": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*18","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*18": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*28","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*28": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*35/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*35": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*36/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*36": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*37/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*37": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*11","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*11": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*13","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*13": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*15","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*15": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*18","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*18": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*28","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*28": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*11","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*11": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*13","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*13": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*15","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*15": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*18","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*18": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*28","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*28": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*11","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*11": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*13","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*13": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*15","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*15": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*18","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*18": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*28","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*28": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*11","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*11": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*13","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*13": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*15","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*15": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*18","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*18": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*28","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*28": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*11","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*11": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*13","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*13": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*15","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*15": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*18","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*18": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*28","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*28": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*38","function1":"Normal function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*38": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*22","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*22": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*24","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*24": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*35","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*35": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*36","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*36": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*37","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*37": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*17","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*17": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*17","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*17": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*17","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*17": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*17","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*17": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*17","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*17": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*17","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*17": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*17","function1":"Increased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*17": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a no function allele OR one copy of an increased function and one copy of a no function allele. Based on the genotype result this patient is predicted to be an intermediate metabolizer of CYP2C19 substrates. This patient may be at risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or alternative therapeutic agents may be necessary for medications metabolized by CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Intermediate Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*22","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*22": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*24","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*24": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*35","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*35": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*36","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*36": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*37","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*37": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*22","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*22": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*24","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*24": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*35","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*35": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*36","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*36": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*37","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*37": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*22","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*22": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*24","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*24": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*35","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*35": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*36","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*36": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*37","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*37": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*10","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*10": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*16","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*16": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*19","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*19": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*25","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*25": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*26","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*26": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*9","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*9": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*25","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*25": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*26","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*26": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*25","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*25": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*26","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*26": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*35","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*35": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*36","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*36": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*37","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*37": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*35","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*35": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*36","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*36": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*37","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*37": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*10","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*10": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*16","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*16": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*19","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*19": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*25","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*25": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*26","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*26": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*9","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*9": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*10","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*10": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*16","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*16": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*19","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*19": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*25","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*25": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*26","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*26": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*9","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*9": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*10","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*10": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*16","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*16": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*19","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*19": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*25","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*25": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*26","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*26": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*9","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*9": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*10","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*10": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*16","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*16": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*19","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*19": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*25","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*25": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*26","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*26": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*9","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*9": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*10","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*10": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*16","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*16": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*19","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*19": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*25","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*25": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*26","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*26": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*9","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*9": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*10","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*10": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*16","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*16": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*19","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*19": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*25","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*25": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*26","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*26": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*9","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*9": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*22","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*22": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*24","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*24": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*35","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*35": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*36","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*36": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*37","function1":"Decreased function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*37": 1}},"generesult":"Likely Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele. Based on the genotype result this patient MAY be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Likely Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*2","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*22","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*22": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*24","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*24": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*3","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*35/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*35": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*36/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*36": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*37/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*37": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*4","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*5","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*5": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*6","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*6": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*7","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*7": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*8","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*8": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*22","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*22": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*24","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*24": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*3","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*3": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*35": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*4","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*4": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*5","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*5": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*6","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*6": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*7","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*7": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*8","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*2": 1, "*8": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*24","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*22": 1, "*24": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*22": 1, "*35": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*22": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*22": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*24": 1, "*35": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*24": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*24": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*22","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*22": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*24","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*24": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*35": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*4","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*4": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*5","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*5": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*6","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*6": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*7","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*7": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*8","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*3": 1, "*8": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*35/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*35": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*35/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*35": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*36/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*36": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*22","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 1, "*22": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*24","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 1, "*24": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 1, "*35": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*5","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 1, "*5": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*6","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 1, "*6": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*7","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 1, "*7": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*8","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*4": 1, "*8": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*22","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*5": 1, "*22": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*24","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*5": 1, "*24": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*5": 1, "*35": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*5": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*5": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*6","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*5": 1, "*6": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*7","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*5": 1, "*7": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*8","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*5": 1, "*8": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*22","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*6": 1, "*22": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*24","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*6": 1, "*24": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*6": 1, "*35": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*6": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*6": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*7","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*6": 1, "*7": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*8","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*6": 1, "*8": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*22","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*7": 1, "*22": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*24","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*7": 1, "*24": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*7": 1, "*35": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*7": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*7": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*8","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*7": 1, "*8": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*22","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*8": 1, "*22": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*24","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*8": 1, "*24": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*35","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*8": 1, "*35": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*36","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*8": 1, "*36": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*37","function1":"No function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two no function alleles","diplotypekey":{"CYP2C19": {"*8": 1, "*37": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of a no function allele. Based on the genotype result this patient is predicted to be a poor metabolizer of CYP2C19 substrates. This patient may be at a high risk for an adverse or poor response to medications that are metabolized by CYP2C19. To avoid an untoward drug response, dose adjustments or or alternative therapy may be necessary for medications metabolized by the CYP2C19. Please consult a clinical pharmacist for more information about how CYP2C19 metabolic status influences drug selection and dosing.","lookupkey":{"CYP2C19" : "Poor Metabolizer"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*12","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*14","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*14": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*23","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*23": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*29","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*29": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*30","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*30": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*31/*31","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*31": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*32/*32","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*32": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*33/*33","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*33": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*34/*34","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*34": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*39/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*39": 2}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*14","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*23","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*29","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*30","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*31","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*32","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*33","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*34","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*12": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*23","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*14": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*29","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*14": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*30","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*14": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*31","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*14": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*32","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*14": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*33","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*14": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*34","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*14": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*14": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*29","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*23": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*30","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*23": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*31","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*23": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*32","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*23": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*33","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*23": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*34","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*23": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*23": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*30","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*29": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*31","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*29": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*32","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*29": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*33","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*29": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*34","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*29": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*29": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*31","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*30": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*32","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*30": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*33","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*30": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*34","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*30": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*30": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*31/*32","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*31": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*31/*33","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*31": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*31/*34","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*31": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*31/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*31": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*32/*33","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*32": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*32/*34","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*32": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*32/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*32": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*33/*34","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*33": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*33/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*33": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*34/*39","function1":"Uncertain function","function2":"Uncertain function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying two uncertain function alleles","diplotypekey":{"CYP2C19": {"*34": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*17","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*17": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*17","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*17": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*23","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*29","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*30","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*31","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*32","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*33","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*34","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*17/*39","function1":"Uncertain function","function2":"Increased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one increased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*17": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*12","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*14","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*23","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*29","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*30","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*31","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*32","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*33","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*34","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*1/*39","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*1": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*12","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*14","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*23","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*29","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*30","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*31","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*32","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*33","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*34","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*11/*39","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*11": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*13","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*13": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*15","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*15": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*18","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*18": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*28","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*28": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*38","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*38": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*14","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*23","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*29","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*30","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*31","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*32","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*33","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*34","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*13/*39","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*13": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*15","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*15": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*18","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*18": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*28","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*28": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*38","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*38": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*23","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*29","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*30","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*31","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*32","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*33","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*34","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*15/*39","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*15": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*23","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*29","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*30","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*31","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*32","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*33","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*34","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*18/*39","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*18": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*28","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*23": 1, "*28": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*38","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*23": 1, "*38": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*29","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*30","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*31","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*32","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*33","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*34","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*28/*39","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*28": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*38","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*29": 1, "*38": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*38","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*30": 1, "*38": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*31/*38","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*31": 1, "*38": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*32/*38","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*32": 1, "*38": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*33/*38","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*33": 1, "*38": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*34/*38","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*34": 1, "*38": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*38/*39","function1":"Uncertain function","function2":"Normal function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one normal function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*38": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*12","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*14","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*23","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*29","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*30","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*31","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*32","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*33","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*34","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*10/*39","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*10": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*16","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*16": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*19","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*19": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*25","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*25": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*26","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*26": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*16","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*16": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*19","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*19": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*25","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*25": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*26","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*26": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*23","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*29","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*30","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*31","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*32","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*33","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*34","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*16/*39","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*16": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*23","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*29","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*30","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*31","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*32","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*33","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*34","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*19/*39","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*19": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*25","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*23": 1, "*25": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*26","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*23": 1, "*26": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*29","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*30","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*31","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*32","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*33","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*34","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*25/*39","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*25": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*29","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*30","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*31","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*32","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*33","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*34","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*26/*39","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*26": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*12","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*14","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*23","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*29","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*30","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*31","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*32","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*33","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*34","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*9/*39","function1":"Uncertain function","function2":"Decreased function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one decreased function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*9": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*22","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*22": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*24","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*24": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*35","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*35": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*36","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*36": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*12/*37","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*12": 1, "*37": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*22","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*22": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*24","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*24": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*35","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*35": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*36","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*36": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*14/*37","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*14": 1, "*37": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*12","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*14","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*23","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*29","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*30","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*31","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*32","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*33","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*34","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*2/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*2": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*23","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*29","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*30","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*31","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*32","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*33","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*34","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*22/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*22": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*24","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*23": 1, "*24": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*35","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*23": 1, "*35": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*36","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*23": 1, "*36": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*23/*37","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*23": 1, "*37": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*29","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*30","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*31","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*32","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*33","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*34","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*24/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*24": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*35","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*29": 1, "*35": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*36","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*29": 1, "*36": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*29/*37","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*29": 1, "*37": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*12","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*14","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*23","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*29","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*30","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*31","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*32","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*33","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*34","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*3/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*3": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*35","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*30": 1, "*35": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*36","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*30": 1, "*36": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*30/*37","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*30": 1, "*37": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*31/*35","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*31": 1, "*35": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*31/*36","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*31": 1, "*36": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*31/*37","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*31": 1, "*37": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*32/*35","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*32": 1, "*35": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*32/*36","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*32": 1, "*36": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*32/*37","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*32": 1, "*37": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*33/*35","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*33": 1, "*35": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*33/*36","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*33": 1, "*36": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*33/*37","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*33": 1, "*37": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*34/*35","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*34": 1, "*35": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*34/*36","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*34": 1, "*36": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*34/*37","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*34": 1, "*37": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*35/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*35": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*36/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*36": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*37/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*37": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*12","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*14","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*23","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*29","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*30","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*31","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*32","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*33","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*34","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*4/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*4": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*12","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*14","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*23","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*29","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*30","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*31","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*32","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*33","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*34","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*5/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*5": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*12","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*14","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*23","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*29","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*30","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*31","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*32","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*33","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*34","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*6/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*6": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*12","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*14","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*23","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*29","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*30","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*31","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*32","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*33","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*34","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*7/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*7": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*12","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*12": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*14","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*14": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*23","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*23": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*29","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*29": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*30","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*30": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*31","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*31": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*32","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*32": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*33","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*33": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*34","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*34": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}, 
 {"genesymbol":"CYP2C19","diplotype":"*8/*39","function1":"Uncertain function","function2":"No function","activityvalue1":"n/a","activityvalue2":"n/a","totalactivityscore":"n/a","description":"An individual carrying one no function allele and one uncertain function allele","diplotypekey":{"CYP2C19": {"*8": 1, "*39": 1}},"generesult":"Indeterminate","ehrpriority":"none","consultationtext":"This result signifies that the patient has an allele combination with uncertain and/or unknown function alleles. The expected phenotype for this patient cannot be determined currently based on the CYP2C19 diplotype result. Please consult a clinical pharmacist for more specific information about how CYP2C19 function influences drug dosing.","lookupkey":{"CYP2C19" : "Indeterminate"}}]